Skip to main content

Speakers

Subpage Hero

Loading
Marshall Summar

Marshall Summar

CEO, Uncommon Cures
EDUCATION
Undergraduate at Vanderbilt University majoring in Molecular Biology and minor in Chemistry (Class 81)
Medical School at University of Tennessee Center for Health Sciences (1982-85)
Pediatric Residency Vanderbilt University (1985-1988)
Genetics Research and Clinical Fellowship (1988-1990)
Board Certification in Pediatrics, Clinical Genetics, and Medical Biochemical Genetics
VANDERBILT UNIVERSITY
Vanderbilt Faculty from 1990-2010 Professor of Pediatrics and Molecular Physiology & Biophysics (tenure)
Director Vanderbilt Program in Translational Genetic Research 2004-2010
Chair, Executive Committee Vanderbilt Ph.D. Program in Human Genetics
Vice-President Vanderbilt University Faculty Senate
Chancellor's Advisory Committee
CHILDREN'S NATIONAL MEDICAL CENTER (Washington DC) & FACULTY GEORGE WASHINGTON UNIVERSITY
Professor of Pediatrics and Integrative Systems Biology (Tenure) 2010-Present
Margaret O'Malley Chair in Molecular Genetics (2010-2023)
Founding Director of Rare Disease Institute (2016-2022)
Division Chief of Genetics and Metabolism (2010-2022)
PROFESSIONAL AND PUBLIC ACTIVITIES
Chair: Scientific and Medical Advisory Board, NORD, 2012-2022
Chair and Member of the Rare Disease Advisory Panel, Patient Centered Outcomes Research Institute (PCORI, 2014-2016)
President: Society for the Study of Inherited Metabolic Disorders, 2015-2017
Chair, Board of Directors, National Organization of Rare Diseases 2016-2020 (member 2012-20)
Board of Directors, Arkansas Children's Research Institute 2020-Present
Board of Directors, PHLOW Pharmaceuticals (uncompensated), Richmond VA, 2020-Present
Co-Director, FDA Forum on Rare Disease Drug Authorization, 2018-2020
Rare Disease Advisory Committee: Black Women's Health Imperative, 2019-Present
Co-Chair: Research Committee, 2019-Present
Council, National Center for Advancing Translational Science (NCATS), NIH, Term starting 2021
Chief Executive Officer: Uncommon Cures LLC, 2022-Present

Sessions

Sponsors